S5 Ep17: Kaklamani's Insights on EMERALD Trial and Elacestrant in Advanced Breast Cancer

from Treating Together · host Targeted Oncology

In this episode of Targeted Talks, Virginia Kaklamani, MD, DSc, professor of medicine in the Division of Hematology-Medical Oncology at The University of Texas Health Science Center San Antonio and the leader of the breast cancer program at the Mays Cancer Center, home to UT Health San Antonio MD Anderson Cancer Center, discusses the background, findings, and implications of the phase 3 EMERALD trial.

Episode metadata supplied by the publisher feed · Published Sep 26, 2024

Embed this episode

Attribution link and audio player

Ready to play

S5 Ep17: Kaklamani's Insights on EMERALD Trial and Elacestrant in Advanced Breast Cancer

0:00 13:41

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Treating Together?

This episode is 13 minutes long.

When was this Treating Together episode published?

This episode was published on September 26, 2024.

Can I download this Treating Together episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!